Alexander D. Cross serves as Executive at LIGAND PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Alexander D. Cross has executed 5 insider transactions totaling $2.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 15, 2013 involved purchasing 500 shares valued at $2.7K.
Alexander D. Cross currently holds 88,866 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alexander D. Cross has been a net buyer of LGND stock. They have purchased $2.7K and sold $0 worth of shares.
Alexander D. Cross's most recent insider trade was on May 15, 2013, when they purchased 500 shares at $5.49 per share.
Get notified when new Form 4 filings are submitted
| $1.26 |
| Discretionary |
| Jun 13, 2007 | NSTK | $0 | Award | 5,500 | $N/A | Discretionary |
| Jun 13, 2006 | NSTK | $0 | Award | 5,000 | $N/A | Discretionary |
| Mar 1, 2006 | LGND | $6.9K | Option Exercise | 1,841 | $3.73 | Discretionary |